Zyprexa (also known as olanzapine) is one of the most successful drugs in the class of drugs known as atypical anti-psychotic medications. Zyprexa was approved by the FDA in 1996. Manufactured and marketed by Eli Lilly, the drug was first approved for treatment of schizophrenia, but is often used off-label to treat dementia and bipolar disorder. Studies as far back as 2001 indicate that Zyprexa causes an alarmingly high increase in the risk of diabetes, hyperglycemia and other blood sugar disorders.

On April 11, 2005, the FDA released news of another warning to be put on the class of drugs known as atypical anti-psychotic medications, including Zyprexa. A recent compiling of over 17 studies showed that off-label use to treat elderly patients with dementia is associated with an increased mortality rate. In the studies, there were nearly twice as many deaths in elderly patients treated with atypical anti-psychotic medications, such as Zyprexa, than in those patients treated with a placebo.

The Suthers Law Firm is currently investigating cases that involve diabetes in all age groups and increased mortality rate in elderly individuals related to Zyprexa. If you or someone you know has suffered serious side effects from taking Zyprexa, contact us online or call us toll free at 1-800-320-2384 to set up a FREE consultation.